|
AlphaganDrug - Alphagan The trade name of the product as shown on the labeling.
Dosage -
SOLUTION/DROPS; OPHTHALMIC
Active Ingredient(s) -
Brimonidine Tartrate
Strength -
0.2%
Applicant -
ALLERGAN
New Drug Application (NDA) Number -
020613
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 6, 1996
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Allergan Inc
Alphagan
Bretylium Tosylate In Dextrose 5% In Plastic Container 400mg/100ml Injectable; Injection
Bretylium Tosylate In Dextrose 5% In Plastic Container 800mg/100ml Injectable; Injection Bretylium Tosylate In Plastic Container 50mg/ml Injectable; Injection Bretylol 50mg/ml Injectable; Injection Alphagan 0.2% Solution/drops; Ophthalmic Bretylium Tosylate In Dextrose 5% In Plastic Container 200mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 400mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 200mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 400mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 200mg/100ml Injectable; Injection NewDrugInformation |